Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy.

Pediatr Nephrol · 2024 · PMC10673980 · PMID 37493956

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a mild trendno p-value reported

Considering the associated average blood pressure values, a gradual dosage reduction of ACEi was attempted but eventually stopped in light of a mild trend of proteinuria increase.

also in 79 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.